Clara Campàs

1.5k total citations
20 papers, 1.2k citations indexed

About

Clara Campàs is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Clara Campàs has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 11 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Clara Campàs's work include Chronic Lymphocytic Leukemia Research (12 papers), Cancer-related Molecular Pathways (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). Clara Campàs is often cited by papers focused on Chronic Lymphocytic Leukemia Research (12 papers), Cancer-related Molecular Pathways (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). Clara Campàs collaborates with scholars based in Spain, United States and France. Clara Campàs's co-authors include Joan Gil, Montserrat Barragán, Antonio F. Santidrián, Beatríz Bellosillo, Gabriel Pons, Dolors Colomer, Mercè de Frías, Ana M. Cosialls, Daniel Iglesias‐Serret and José M. López and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biochemical Journal.

In The Last Decade

Clara Campàs

20 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Clara Campàs Spain	16	773	385	248	211	161	20	1.2k
Ling Cen United States	17	626 0.8×	569 1.5×	290 1.2×	197 0.9×	251 1.6×	44	1.3k
Nina Fenouille France	15	849 1.1×	354 0.9×	112 0.5×	228 1.1×	199 1.2×	17	1.5k
Yongdong Feng China	26	972 1.3×	641 1.7×	92 0.4×	397 1.9×	326 2.0×	64	1.7k
Monika Podhorecka Poland	14	600 0.8×	333 0.9×	247 1.0×	166 0.8×	234 1.5×	51	1.2k
Haluk Yuzugullu France	10	1.4k 1.8×	541 1.4×	226 0.9×	305 1.4×	154 1.0×	12	1.8k
Akintunde Akinleye United States	11	660 0.9×	742 1.9×	248 1.0×	164 0.8×	343 2.1×	13	1.5k
HP Koeffler United States	18	975 1.3×	534 1.4×	113 0.5×	178 0.8×	232 1.4×	41	1.5k
Claire Fabre France	19	752 1.0×	444 1.2×	117 0.5×	222 1.1×	234 1.5×	43	1.3k
Ruoping Tang France	24	675 0.9×	729 1.9×	386 1.6×	173 0.8×	436 2.7×	40	1.7k
Rui-Yu Wang United States	14	964 1.2×	669 1.7×	243 1.0×	262 1.2×	336 2.1×	20	1.7k

Countries citing papers authored by Clara Campàs

Since Specialization

Citations

This map shows the geographic impact of Clara Campàs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clara Campàs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clara Campàs more than expected).

Fields of papers citing papers by Clara Campàs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clara Campàs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clara Campàs. The network helps show where Clara Campàs may publish in the future.

Co-authorship network of co-authors of Clara Campàs

This figure shows the co-authorship network connecting the top 25 collaborators of Clara Campàs. A scholar is included among the top collaborators of Clara Campàs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clara Campàs. Clara Campàs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Montraveta, Arnau, Sílvia Xargay‐Torrent, Laia Rosich, et al.. (2015). Bcl-2highmantle cell lymphoma cells are sensitized to acadesine with ABT-199. Oncotarget. 6(25). 21159–21172. 10 indexed citations

Montraveta, Arnau, Sílvia Xargay‐Torrent, Mònica López‐Guerra, et al.. (2014). Synergistic anti-tumor activity of acadesine (AICAR) in combination with the anti-CD20 monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphoma. Oncotarget. 5(3). 726–739. 16 indexed citations

Neste, Eric Van Den, Bruno Cazin, Ann Janssens, et al.. (2012). Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II study. Cancer Chemotherapy and Pharmacology. 71(3). 581–591. 44 indexed citations

Montraveta, Arnau, Mercè de Frías, Clara Campàs, et al.. (2011). Abstract A209: The nucleoside analogue acadesine exerts antitumoral activity and cooperates with anti-CD20 monoclonal antibodies in in vitro and in vivo models of mantle cell lymphoma.. Molecular Cancer Therapeutics. 10(11_Supplement). A209–A209. 2 indexed citations

Montraveta, Arnau, Mercè de Frías, Clara Campàs, et al.. (2010). The Nucleoside Analogue Acadesine Exerts Antitumoral Activity and Cooperates with Conventional Agents In In Vitro and In Vivo Models of Mantle Cell Lymphoma. Blood. 116(21). 3918–3918. 2 indexed citations

Santidrián, Antonio F., Diana M. González‐Gironès, Daniel Iglesias‐Serret, et al.. (2010). AICAR induces apoptosis independently of AMPK and p53 through up-regulation of the BH3-only proteins BIM and NOXA in chronic lymphocytic leukemia cells. Blood. 116(16). 3023–3032. 90 indexed citations

Rojo, Federico, Teresa Cruz, Josep Corominas, et al.. (2010). Pharmacodynamic Trial of Nimotuzumab in Unresectable Squamous Cell Carcinoma of the Head and Neck: A SENDO Foundation Study. Clinical Cancer Research. 16(8). 2474–2482. 50 indexed citations

Rojo, Federico, Rafael Bragado, Alba Dalmases, et al.. (2009). Mitogen-Activated Protein Kinase Phosphatase-1 in Human Breast Cancer Independently Predicts Prognosis and Is Repressed by Doxorubicin. Clinical Cancer Research. 15(10). 3530–3539. 51 indexed citations

Rojo, Federico, et al.. (2008). Pharmacodynamic study of nimotuzumab, an anti-epidermal growth factor receptor (EGFR) monoclonal antibody (MAb), in patients with unresectable squamous cell carcinoma of the head and neck (SCCHN): A SENDO Foundation study. Journal of Clinical Oncology. 26(15_suppl). 6070–6070. 5 indexed citations

10.

Santidrián, Antonio F., Ana M. Cosialls, Daniel Iglesias‐Serret, et al.. (2007). The potential anticancer agent PK11195 induces apoptosis irrespective of p53 and ATM status in chronic lymphocytic leukemia cells. Haematologica. 92(12). 1631–1638. 25 indexed citations

11.

Montagut, Clara, Ignasi Tusquets, Berta Ferrer-Rosell, et al.. (2006). Activation of nuclear factor-κ B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients. Endocrine Related Cancer. 13(2). 607–616. 85 indexed citations

12.

Campàs, Clara, Ana M. Cosialls, Montserrat Barragán, et al.. (2006). Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells. Experimental Hematology. 34(12). 1663–1669. 65 indexed citations

13.

Barragán, Montserrat, Mercè de Frías, Daniel Iglesias‐Serret, et al.. (2006). Regulation of Akt/PKB by phosphatidylinositol 3-kinase-dependent and -independent pathways in B-cell chronic lymphocytic leukemia cells: role of protein kinase Cβ. Journal of Leukocyte Biology. 80(6). 1473–1479. 45 indexed citations

14.

Domingo‐Domenech, Josep, Cristina Oliva, Ana Rovira, et al.. (2006). Interleukin 6, a Nuclear Factor-κB Target, Predicts Resistance to Docetaxel in Hormone-Independent Prostate Cancer and Nuclear Factor-κB Inhibition by PS-1145 Enhances Docetaxel Antitumor Activity. Clinical Cancer Research. 12(18). 5578–5586. 141 indexed citations

15.

Coll-Mulet, Llorenç, Daniel Iglesias‐Serret, Antonio F. Santidrián, et al.. (2006). MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells. Blood. 107(10). 4109–4114. 181 indexed citations

16.

Barragán, Montserrat, Clara Campàs, Beatríz Bellosillo, & Joan Gil. (2003). Protein Kinases in the Regulation of Apoptosis in B-cell Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 44(11). 1865–1870. 18 indexed citations

17.

Campàs, Clara, Beatriz Montaner, Montserrat Barragán, et al.. (2003). Prodigiosin induces apoptosis of B and T cells from B-cell chronic lymphocytic leukemia. Leukemia. 17(4). 746–750. 89 indexed citations

18.

Campàs, Clara, José M. López, Antonio F. Santidrián, et al.. (2003). Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytes. Blood. 101(9). 3674–3680. 121 indexed citations

19.

López, José M., Antonio F. Santidrián, Clara Campàs, & Joan Gil. (2003). 5-Aminoimidazole-4-carboxamide riboside induces apoptosis in Jurkat cells, but the AMP-activated protein kinase is not involved. Biochemical Journal. 370(3). 1027–1032. 59 indexed citations

20.

Barragán, Montserrat, Beatríz Bellosillo, Clara Campàs, et al.. (2002). Involvement of protein kinase C and phosphatidylinositol 3–kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells. Blood. 99(8). 2969–2976. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact